AusCann Group Holdings Limited announced that as part of the Board renewal process announced on 28 October 2019, the Company has appointed Mr. Max Johnston and Mrs. Krista Bates as Non-Executive Directors of AusCann, effective immediately. Mr. Max Johnston will also be appointed Chairman of AusCann effective from the departure of Interim Chairman Hon. Cheryl Edwardes AM on 19 January 2020. Mr. Johnston is a highly regarded health care industry director with a wealth of executive and pharmaceutical experience. He is currently a Non-Executive Director on the Boards of ASX-listed companies BARD1 Life Sciences, PolyNovo, CannPal Animal Therapeutics and Medical Developments International. Mr. Johnston previously held the position of President and Chief Executive Officer of Johnson & Johnson Pacific.